Sesha Neervannan
Chief Operating Officer bei TARSUS PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Sesha Neervannan is currently the Chief Operating Officer at Tarsus Pharmaceuticals, Inc. He previously worked as the Director of Pharmaceutics R&D at Amgen, Inc. from 1999 to 2007, and as the Senior Vice President of Global Pharmaceutical Development at Allergan, Inc. from 2015 to 2020.
Prior to that, he was a Senior Research Investigator at Bristol-Myers Squibb Pharmaceutical Research Institute from 1994 to 1999.
Neervannan received his undergraduate degree from Birla Institute of Technology & Science and his doctorate from the University of Kansas in 2019.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 64 767 ( 0,17% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Sesha Neervannan
| Unternehmen | Position | Beginn |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Chief Operating Officer | 16.07.2020 |
Ehemalige bekannte Positionen von Sesha Neervannan
| Unternehmen | Position | Ende |
|---|---|---|
| ALLERGAN, INC. | Corporate Officer/Principal | 01.07.2020 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01.01.2007 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | 01.02.1999 |
| Greater Irvine Chamber of Commerce | Director/Board Member | - |
Ausbildung von Sesha Neervannan
| Birla Institute of Technology & Science | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
| Greater Irvine Chamber of Commerce |
